Cepheid has introduced the GeneXpert ® 16-Site System at the 106th Annual Meeting of the American Society for Microbiology. Cepheid claims that, batch processing is no longer the only option, as ...

Renowned molecular diagnostics provider Cepheid CPHD recently entered into a non-exclusive distribution agreement with Henry Schein Medical, the Medical business of one of the leading healthcare ...

Collaboration to leverage Oxford Nanopore's sequencing platform and Cepheid's GeneXpert system to advance the field of sequencing for infectious diseases OXFORD, United Kingdom and SUNNYVALE, Calif., ...

SpeeDx to bring first sample-to-answer Mycoplasma genitalium and macrolide resistance test to Europe SYDNEY--(BUSINESS WIRE)--SpeeDx Pty, Ltd. today announced the European launch of ResistancePlus® MG ...

SYDNEY--(BUSINESS WIRE)--SpeeDx Pty, Ltd. today announced ResistancePlus® MG FleXible for the Cepheid GeneXpert® System, detecting the sexually transmitted infection (STI) Mycoplasma genitalium (Mgen) ...

Cepheid, a leading molecular diagnostics company, and FIND, an international non-profit organisation, launched the GeneXpert Omni, the world's most portable molecular diagnostics system enabling ...

Cepheid has introduced the GeneXpert ® 16-Site System at the 106th Annual Meeting of the American Society for Microbiology. The latest addition to Cepheid's GeneXpert ® family of real-time PCR devices ...

Cepheid, a leading molecular diagnostics company, announced an agreement with Henry Schein Medical, the US Medical business of Henry Schein, Inc., for the distribution of its GeneXpert System and menu ...